Atlas Trials

Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

Clinical trial NCT05113576 · COMPLETED

Trial details

NCT number
NCT05113576
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
COMPLETED
Study type
OBSERVATIONAL
Diffuse Large B-cell Lymphoma
Start date
2013-10-10
Primary completion
2020-05-30
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.